Amantadine is a medication used to treat dyskinesia in Parkinson's patients receiving levodopa, as well as extrapyramidal side effects of medications. Identification · Pharmacology · Interactions · Products

An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal ...

Amantadine, A medication used to treat dyskinesia in Parkinson's patients receiving levodopa, as well as extrapyramidal side effects of medications.

Associated Data ; NCT06443827. Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness. Amantadine ; NCT04367883. Influenza Vaccination, ACEI and ...

Also known as: Product containing amantadine (medicinal product) / Amantadine (substance). Drug Trials. Drug, Drug Name, Drug Description ...

Amantadine completed Phase 3 trials for dyskinesia / Levodopa induced dyskinesias (LID) / Parkinson's Disease (PD) treatment.

Abstract. Amantadine is an antiviral agent that was unexpectedly found to cause symptomatic improvement in patients with Parkinsonism, although its ...

Amantadine is a D(2) dopamine receptor agonist. 1, D(2) dopamine receptor ... Amantadine is a Glutamate receptor ionotropic, NMDA 3A antagonist. 1 ...

Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. · Article Details · DrugBank Data that Cites this Article · Stay up-to-date ...

Our results confirm that amantadine binding inhibits current flow through NMDA receptor channels but show that its main inhibitory action at pharmaceutically ...